{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-021653","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.013145+00:00","generated_at":"2026-06-24T02:45:54.518413+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MariMed Q2 revenue $33.0M (+1% YoY); GAAP net income falls 75% to $1.9M","bullets":["Revenue $33.0M vs $32.6M year ago; gross margin dropped to 45% from 60%.","GAAP net income $1.9M vs $7.6M; Non-GAAP Adjusted EBITDA $8.9M vs $13.9M.","Working capital declined to $8.9M from $13.9M; no guidance provided.","CEO cited increased dispensary traffic despite industry headwinds and 40-year high inflation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-021653","json":"https://secwatch.observer/filing/0001493152-22-021653.json","markdown":"https://secwatch.observer/filing/0001493152-22-021653.md","text":"https://secwatch.observer/filing/0001493152-22-021653.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222021653/0001493152-22-021653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222021653/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:45:54.518413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}